The FINANCIAL -- GlaxoSmithKline’s (GSK) oral targeted agent Tyverb (lapatinib) demonstrated single agent activity and improvement in clinical response to...
The FINANCIAL -- Bayer Schering Pharma´s YAZ will be available across Europe as of September 2008. YAZ is the first...
The FINANCIAL -- Sanofi-aventis announced today the completion of the acquisition of the Australian company Symbion CP Holdings Pty Limited...
The FINANCIAL -- According to Lilly, patients who were diabetic and diagnosed with acute coronary syndromes (ACS) were 40 percent...
The FINANCIAL -- According to Bayer, the development of Xarelto (rivaroxaban), a novel oral anticoagulant, has taken another step forward....
The FINANCIAL -- According to Lilly, data from a new study suggest that Cymbalta (duloxetine HCl) 60-120 mg once daily significantly...
The FINANCIAL -- Eli Lilly and Company (NYSE: LLY) on August 4 reaffirmed that its $3.00 per share purchase offer for SGX Pharmaceutical,...
The FINANCIAL -- The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT (valsartan and...
The FINANCIAL -- According to PRNewswire, The Tennessee Pharmacists Association (TPA) announced on July 21 that the Tennessee Pharmacists Research...
The FINANCIAL -- GlaxoSmithKline (GSK) and Actelion Ltd (SWX: ATLN) announced today that they have entered into an exclusive worldwide...
The FINANCIAL -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced on June 16 its commitment to donate 60 million doses...
The FINANCIAL -- Bayer CropScience has opened a rice research laboratory in Singapore dedicated to support the development of new...
The FINANCIAL -- Association’s (ADA) 68th Annual Scientific Sessions reinforce the importance of promptly initiating insulin treatment when patients with...
The FINANCIAL -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) on June 7 announced additional results from...
The FINANCIAL -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY), and Alkermes, Inc. (Nasdaq: ALKS) announced...